3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
5
Melanoma
4
Glioblastoma
4
Carcinoma
4
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Neoplasms
2
Fibrolamellar hepatocellular carcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Merkel Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms, Squamous Cell
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Interventions
Cyclophosphamide
47
Rituximab
31
fludarabine
29
Specimen Handling
13
Magnetic Resonance Spectroscopy
13
Doxorubicin
13
pirtobrutinib
11
Vincristine
11
Prednisone
11
fludarabine phosphate
10
Immunotherapy, Adoptive
10
Etoposide
10
Bendamustine Hydrochloride
10
obinutuzumab
8
Lenalidomide
8
Biopsy
8
venetoclax
7
polatuzumab vedotin
7
glofitamab
7
zanubrutinib
6
pembrolizumab
6
Dexamethasone
6
tafasitamab
5
ibrutinib
5
etoposide phosphate
5
acalabrutinib
5
Leukapheresis
5
tazemetostat
4
loncastuximab tesirine
4
Nivolumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
poly ICLC
×
1 year
×
Clear all
No trials found.